Individuals with diabetes are more prone to cardiovascular morbidity and mortality. However, because their low-density lipoprotein (LDL) cholesterol is similar to that of the general population, they do not usually receive statin or other cholesterol-lowering therapy.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Statin therapy decreases risk of macrovascular disease and death in diabetic patients

Newsletter